Leuprolide injection emulsion, a subsidiary of Changchun Hi-Tech Holdings, was approved for clinical use
Time of Update: 2022-04-26
Changchun Hi-Tech announced that its holding subsidiary Jinsai Pharmaceuticals Leuprolide Injection Emulsion has recently received a drug clinical trial approval notice from NMPA . According to the
CSPC submits 4 types of generic marketing applications for rosuvastatin calcium tablets
Time of Update: 2022-03-03
When the rosuvastatin reported for production this time is successfully approved, it will soon become the company's fourth It is a lipid-lowering drug, and at the same time, it has increased the product line of CSPC in the field of blood lipid regulators .
Notice of the State Food and Drug Administration on Issuing the Catalogue of Generic Drug Reference Preparations (Fifty Batch) (No. 9, 2022
Time of Update: 2022-03-02
Notice of the State Food and Drug Administration on Issuing the Catalogue of Generic Drug Reference Preparations (Fifty Batch) (No.
Attachment: Catalogue of Generic Drug Reference Preparations (Fifty Batch) State Food and Drug Administration February 10, 2022 Relevant attachments serial number accessory name 1 Annex to the Circular No.
Zeposia (ozanimod) treats adult patients with moderate to severe active ulcerative colitis, CHMP holds positive opinions
Time of Update: 2021-10-19
Manage ulcerative colitisCHMP adopted this positive opinion based on data from the True North trial, a pivotal phase III trial that evaluates the effectiveness and safety of Zeposia in the treatment of moderate to severely active UC adults .
The national drug procurement with volume has entered the era of "big merger" competition
Time of Update: 2021-06-22
2 requires exploring the merger of different generic drugs with similar indications or functions and indications to carry out centralized and high-volume procurement .
Translational Psychiatry: Female marijuana addicts have smaller local brain areas
Time of Update: 2021-05-21
Among recreational and dependent cannabis users, one side OFC and cerebellar white matter volume were found to be predictable by gender and alcohol dose, but not from cannabis use measurement.
Dongsong medicine and a new class of drugs hit the impact of a surge of 900% insulin
Time of Update: 2021-01-30
source: CDE official heC88473 injection is the first new class 1 drug to submit a clinical application in 2021; Degu insulin injection is a new, ultra-long-effect insulin analogue,2 Global sales exceeded US$1.5 billion in 2019, and in the first half of 2020, terminal sales of urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) exceeded 50 million, up 922.6% YoY.
In August, a large number of pharmaceutical companies announced the suspension of production, suspension of business activities
Time of Update: 2020-11-19
According to incomplete statistics, since August, in addition to Jiangxi Province, Sichuan, Chongqing, Hainan, Fujian, Henan, Gansu, Liaoning, Heilongjiang, Yunnan, Jiangxi and other local drug regulatory bureaus have also issued a pharmaceutical company announced the suspension of production, suspension or closure of business activities.
Health-care catalog negotiations launched more than 130 new drugs or health insurance in the fourth quarter
Time of Update: 2020-09-20
Xiong Xianjun, director of the medical service management department of the National Health Insurance Administration, said that this year's adjustment of the medical insurance catalogue will still take into account the functional positioning of basic medical insurance, clinical needs of drugs and fund affordability.
New psoriasis drug! Johnson and Johnson IL-12/23 inhibitor Stelara (Sidano) was approved by the U.S. FDA for the treatment of pediatric patients aged 6-11
Time of Update: 2020-08-06
July 31, 2020 // Johnson and Johnson (JNJ) Janssen Pharmaceuticals (JNJ) recently announced that the U.S. Food and Drug Administration (FDA) has approved the anti-inflammatory drug Stelara (Chinese product name: Starno, generic name: ustekinumab, Ustenu mono-anti-injection) expanded indications for the treatment of moderate to severe plaque type psoriasis (PsO) pediatric patients (ages 6-11).
Poor efficacy! Johnson and Johnson terminated Stelara's treatment of systemic lupus global Phase III clinical
Time of Update: 2020-07-18
Guide: Stelara showed no significant efficacy compared to placebo Johnson and Johnson's Janssen Pharmaceuticals recently announced its decision to discontinue the evaluation of the anti-inflammatory
DPP-4 hypoglycemic drug turbulence: linagliptin is approved for the first imitation and vildagliptin enters new manufacturers
Time of Update: 2020-07-17
On July 13, Linagliptin, a four-class generic drug from Guangdong East Sunshine Pharmaceuticals, and Vildagliptin, a four-class generic drug from Nanjing Sun Pharmaceuticals, were approved in China on
Since September this year, 33 pilot county hospitals in Fujian have achieved zero drug price differentials
Time of Update: 2020-05-12
since September this year, fujian 33 pilot counties hospitals achieve the drug zero price time: 2014-06-21 08:23:35 Source: Straits Metropolis Daily ( 0 ) yesterday, the province's county-leve
Pharmacies should pay attention to the modification instructions of several common drugs
Time of Update: 2020-01-12
Source: State Food and Drug Administration Sorting out: saibelan - drugstore Manager Recently, according to the evaluation results of adverse drug reactions, in order to further ensure the safety of p
Baiji Shenzhou announced that nmpa has accepted the listing application for new indications of imported drugs from rifeme
Time of Update: 2019-12-24
Beijing, China and Cambridge, Ma, December 23, 2019 / AP / -- Baiji Shenzhou (NASDAQ Code: bgne; Hong Kong stock exchange code: 06160) is a biomedical company in the commercial stage, focusing on the